Soleno Therapeutics (SLNO) EPS (Basic) Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 139.68% |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 25.99% |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 41.58% |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 14.28% |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | 58.35% |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -2.92% |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 45.92% |
| 10 | Soleno Therapeutics | 2.76 Bn | 2.51 Bn | 93.41 Mn | 38.93% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 38.93% |
| Dec 31, 2025 | 52.09% |
| Sep 30, 2025 | 40.17% |
| Jun 30, 2025 | 50.00% |
| Mar 31, 2025 | 3.89% |
| Dec 31, 2024 | -34.86% |
| Sep 30, 2024 | -6.15% |
| Jun 30, 2024 | -59.68% |
| Mar 31, 2024 | -75.05% |
| Dec 31, 2023 | 214.14% |
| Sep 30, 2023 | -105.17% |
| Jun 30, 2023 | -71.71% |
| Mar 31, 2023 | -89.17% |
| Dec 31, 2022 | -12.82% |
| Sep 30, 2022 | -187.11% |
| Jun 30, 2022 | -32.43% |
| Mar 31, 2022 | -69.43% |
| Dec 31, 2021 | -169.93% |
| Sep 30, 2021 | -127.47% |
| Jun 30, 2021 | 26.32% |
| Mar 31, 2021 | 16.65% |
| Dec 31, 2020 | 69.99% |
| Sep 30, 2020 | 24.93% |
| Jun 30, 2020 | 27.51% |
| Mar 31, 2020 | 31.25% |
| Dec 31, 2019 | 51.12% |
| Sep 30, 2019 | 26.71% |
| Jun 30, 2019 | -10.46% |
| Mar 31, 2019 | 90.00% |
| Dec 31, 2018 | 32.64% |
| Sep 30, 2018 | 26.69% |
| Jun 30, 2018 | -50.37% |
| Mar 31, 2018 | 51.54% |
| Dec 31, 2017 | -34.83% |
| Sep 30, 2017 | 61.25% |
| Jun 30, 2017 | 56.80% |
| Mar 31, 2017 | 36.47% |
| Dec 31, 2016 | -22.43% |
| Sep 30, 2016 | 33.59% |